Remogliflozin Etabonate Hydrate-impurities | Pharmaffiliates

Remogliflozin Etabonate Hydrate

Remogliflozin Etabonate Hydrate has been used in trials studying the treatment and basic science of Type 2 Diabetes Mellitus and Diabetes Mellitus, Type 2. Reference standards of Remogliflozin Etabonate Hydrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Remogliflozin Etabonate Hydrate - API Standards
    [catalogue_number] => PA 18 1610000
    [category_ids] => ,78,70,82,
    [chemical_name] => 
    [weight] => 1063.21
    [form] => C52H78N4O19
    [cas] => NA
    [pslug] => remogliflozin-etabonate-hydrate-api-standards-pa181610000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 18 1610000

Remogliflozin Etabonate Hydrate - API Standards


  • Catalogue No.:PA 18 1610000

  • CAS :

    NA

  • Molecular Formula : C52H78N4O19

  • Molecular Weight : 1063.21